CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Jong Keon | - |
dc.contributor.author | Byun, Jae Ho | - |
dc.contributor.author | Kang, Ji Hun | - |
dc.contributor.author | Son, Jung Hee | - |
dc.contributor.author | Kim, Jin Hee | - |
dc.contributor.author | Lee, Seung Soo | - |
dc.contributor.author | Kim, Hyoung Jung | - |
dc.contributor.author | Yoo, Changhoon | - |
dc.contributor.author | Kim, Kyu-pyo | - |
dc.contributor.author | Hong, Seung-Mo | - |
dc.contributor.author | Seo, Dong-Wan | - |
dc.contributor.author | Kim, Song Cheol | - |
dc.contributor.author | Lee, Moon-Gyu | - |
dc.date.accessioned | 2023-09-04T07:15:39Z | - |
dc.date.available | 2023-09-04T07:15:39Z | - |
dc.date.created | 2023-07-21 | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 0938-7994 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/189708 | - |
dc.description.abstract | Objectives We aimed to assess the ability of CT-determined resectability, as defined by a recent version of NCCN criteria, and associated CT findings to predict margin-negative (R0) resection in patients with PDAC after neoadjuvant FOLFIRINOX chemotherapy. Methods Sixty-four patients (36 men and 28 women; mean age, 58.8 years) with borderline resectable or unresectable PDAC who received neoadjuvant FOLFIRINOX were evaluated retrospectively. CT findings were independently assessed by two abdominal radiologists according to NCCN criteria (version 3. 2019). Tumor resectability was classified as resectable, borderline resectable, or unresectable, and change in resectability was classified as regression, stability, or progression. The associations of R0 resection rate with CT-determined resectability and change in resectability categories were evaluated, as were the sensitivity and specificity of NCCN criteria for R0 resection. Factors associated with R0 resection were identified by logistic regression analysis. Results R0 resection rate did not differ significantly among the resectable, borderline resectable, or unresectable PDAC (67-73%,p = 0.95) or among PDAC with regression, stability, or progression (56-77%,p = 0.39). The sensitivity and specificity for R0 resection were 67% and 37%, respectively, for resectability (resectable/borderline vs. unresectable) and 80% and 21%, respectively, for changes in resectability (regression/stable vs. progression). Low-contrast enhancement of soft tissue contacting artery (<= 46.4 HU) was independently associated with R0 resection (p = 0.01). Conclusion CT-determined resectability after neoadjuvant FOLFIRINOX chemotherapy was relatively insensitive and non-specific for predicting R0 resection. Low-contrast enhancement of soft tissue contacting artery may increase the ability of CT to predict R0 resection. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.title | CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Ji Hun | - |
dc.identifier.doi | 10.1007/s00330-020-07188-8 | - |
dc.identifier.scopusid | 2-s2.0-85089867923 | - |
dc.identifier.wosid | 000563174000005 | - |
dc.identifier.bibliographicCitation | EUROPEAN RADIOLOGY, v.31, no.2, pp.813 - 823 | - |
dc.relation.isPartOf | EUROPEAN RADIOLOGY | - |
dc.citation.title | EUROPEAN RADIOLOGY | - |
dc.citation.volume | 31 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 813 | - |
dc.citation.endPage | 823 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordAuthor | Pancreatic neoplasm | - |
dc.subject.keywordAuthor | Neoadjuvant therapy | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Pancreatectomy | - |
dc.subject.keywordAuthor | Neoplasm staging | - |
dc.identifier.url | https://link.springer.com/article/10.1007/s00330-020-07188-8 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.